GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Saroja Pharma Industries India Ltd (NSE:SAROJA) » Definitions » Equity-to-Asset

Saroja Pharma Industries India (NSE:SAROJA) Equity-to-Asset : 0.55 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Saroja Pharma Industries India Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Saroja Pharma Industries India's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹146.4 Mil. Saroja Pharma Industries India's Total Assets for the quarter that ended in Mar. 2024 was ₹265.6 Mil. Therefore, Saroja Pharma Industries India's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.55.

The historical rank and industry rank for Saroja Pharma Industries India's Equity-to-Asset or its related term are showing as below:

NSE:SAROJA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.11   Med: 0.25   Max: 0.55
Current: 0.55

During the past 4 years, the highest Equity to Asset Ratio of Saroja Pharma Industries India was 0.55. The lowest was 0.11. And the median was 0.25.

NSE:SAROJA's Equity-to-Asset is ranked worse than
55.43% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs NSE:SAROJA: 0.55

Saroja Pharma Industries India Equity-to-Asset Historical Data

The historical data trend for Saroja Pharma Industries India's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saroja Pharma Industries India Equity-to-Asset Chart

Saroja Pharma Industries India Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
0.11 0.26 0.24 0.55

Saroja Pharma Industries India Semi-Annual Data
Mar21 Mar22 Mar23 Mar24
Equity-to-Asset 0.11 0.26 0.24 0.55

Competitive Comparison of Saroja Pharma Industries India's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saroja Pharma Industries India's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Saroja Pharma Industries India's Equity-to-Asset falls into.


;
;

Saroja Pharma Industries India Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Saroja Pharma Industries India's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=146.415/265.624
=0.55

Saroja Pharma Industries India's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=146.415/265.624
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Saroja Pharma Industries India  (NSE:SAROJA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Saroja Pharma Industries India Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Saroja Pharma Industries India's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Saroja Pharma Industries India Business Description

Traded in Other Exchanges
N/A
Address
Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080
Saroja Pharma Industries India Ltd is a company engaged in pharmaceutical and healthcare sector. The Company trades in Pharma Active Pharmaceutical Ingredients, Pharma Intermediates, Chemicals, Solvents used for pharmaceutical products human and veterinary medicines. The Company has only one reportable Business Segment which is Pharma Chemicals like Thionyl Chloride and Pharmaceuticals intermeddles etc.

Saroja Pharma Industries India Headlines

No Headlines